Akinchan Bhardwaj։ OCEANIC-STROKE Trial Signals a New Era in Secondary Stroke Prevention
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn:
”A new antithrombotic strategy may finally reduce recurrent ischemic stroke without increasing bleeding
At the American Stroke Association International Stroke Conference 2026, the OCEANIC-STROKE trial presented an important signal in secondary stroke prevention.
Asundexian, a Factor XIa inhibitor, when added to standard antiplatelet therapy, reduced recurrent ischemic stroke without increasing major bleeding.
Key takeaways from this late-breaking abstract:
- ~26% relative reduction in recurrent ischemic stroke
- Reduction in disabling stroke
- No increase in intracranial or major bleeding
- Consistent benefit across age, sex, and stroke subtype
- Favorable composite cardiovascular outcomes
Why this matters:
For decades, efforts to intensify antithrombotic therapy after non-cardioembolic ischemic stroke have been constrained by bleeding risk. FXIa inhibition targets thrombosis biology more selectively, potentially separating efficacy from hemorrhage: “a long-standing unmet need”in stroke prevention.
Important context:
• Phase III, >12,000 patients, global trial
• Non-cardioembolic ischemic stroke / high-risk TIA
• Results are preliminary (conference abstract, not yet peer-reviewed)
If confirmed, FXI inhibition may represent a meaningful shift in how we think about long-term secondary stroke prevention.
Looking forward to the full manuscript and imaging substudy data.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 12:53Bastu Odoka: What Happened to Blood Donation?
-
Sep 25, 2026, 12:43Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies
-
Sep 25, 2026, 12:14Garima Sharma: Community Clinical Linkages for Better Postpartum Cardiovascular Care
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD